112 related articles for article (PubMed ID: 23277918)
1. Genomic polymorphisms in 3β-hydroxysterol Δ24-reductase promoter sequences.
Salem NE; Saito M; Kasama Y; Ozawa M; Kawabata T; Harada S; Suda H; Asonuma K; El-Gohary A; Tsukiyama-Kohara K
Microbiol Immunol; 2013 Mar; 57(3):179-84. PubMed ID: 23277918
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus promotes expression of the 3β-hydroxysterol δ24-reductase through Sp1.
Saito M; Kohara M; Tsukiyama-Kohara K
J Med Virol; 2012 May; 84(5):733-46. PubMed ID: 22431021
[TBL] [Abstract][Full Text] [Related]
3. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
[TBL] [Abstract][Full Text] [Related]
4. 3β-hydroxysterol δ24-reductase on the surface of hepatitis C virus-related hepatocellular carcinoma cells can be a target for molecular targeting therapy.
Saito M; Takano T; Nishimura T; Kohara M; Tsukiyama-Kohara K
PLoS One; 2015; 10(4):e0124197. PubMed ID: 25875901
[TBL] [Abstract][Full Text] [Related]
5. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.
Itakura J; Nagayama K; Enomoto N; Sakamoto N; Tazawa J; Izumi N; Marumo F; Sato C
J Med Virol; 2001 Jan; 63(1):22-8. PubMed ID: 11130883
[TBL] [Abstract][Full Text] [Related]
6. Role of oxidative stress in hepatocarcinogenesis induced by hepatitis C virus.
Tsukiyama-Kohara K
Int J Mol Sci; 2012 Nov; 13(11):15271-8. PubMed ID: 23203124
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes.
Takano T; Tsukiyama-Kohara K; Hayashi M; Hirata Y; Satoh M; Tokunaga Y; Tateno C; Hayashi Y; Hishima T; Funata N; Sudoh M; Kohara M
J Hepatol; 2011 Sep; 55(3):512-521. PubMed ID: 21184787
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody 2-152a suppresses hepatitis C virus infection through betaine/GABA transporter-1.
Satoh M; Saito M; Takano T; Kasama Y; Nishimura T; Nishito Y; Hirata Y; Arai M; Sudoh M; Kai C; Kohara M; Tsukiyama-Kohara K
J Infect Dis; 2011 Oct; 204(8):1172-80. PubMed ID: 21917889
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase.
Nishimura T; Kohara M; Izumi K; Kasama Y; Hirata Y; Huang Y; Shuda M; Mukaidani C; Takano T; Tokunaga Y; Nuriya H; Satoh M; Saito M; Kai C; Tsukiyama-Kohara K
J Biol Chem; 2009 Dec; 284(52):36442-36452. PubMed ID: 19861417
[TBL] [Abstract][Full Text] [Related]
11. Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
Ikeda A; Shimizu T; Matsumoto Y; Fujii Y; Eso Y; Inuzuka T; Mizuguchi A; Shimizu K; Hatano E; Uemoto S; Chiba T; Marusawa H
Gastroenterology; 2014 Jan; 146(1):222-32.e35. PubMed ID: 24055508
[TBL] [Abstract][Full Text] [Related]
12. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis.
Zerenturk EJ; Sharpe LJ; Ikonen E; Brown AJ
Prog Lipid Res; 2013 Oct; 52(4):666-80. PubMed ID: 24095826
[TBL] [Abstract][Full Text] [Related]
13. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
14. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
Kasai D; Adachi T; Deng L; Nagano-Fujii M; Sada K; Ikeda M; Kato N; Ide YH; Shoji I; Hotta H
J Hepatol; 2009 May; 50(5):883-94. PubMed ID: 19303158
[TBL] [Abstract][Full Text] [Related]
15. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection.
Bouzgarrou N; Hassen E; Schvoerer E; Stoll-Keller F; Bahri O; Gabbouj S; Cheikh I; Maamouri N; Mammi N; Saffar H; Trabelsi A; Triki H; Chouchane L
J Med Virol; 2008 Apr; 80(4):607-14. PubMed ID: 18297714
[TBL] [Abstract][Full Text] [Related]
16. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
[TBL] [Abstract][Full Text] [Related]
17. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
18. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
20. Constitutive androstane receptor transactivates the hepatic expression of mouse Dhcr24 and human DHCR24 encoding a cholesterogenic enzyme 24-dehydrocholesterol reductase.
Yoshinari K; Ohno H; Benoki S; Yamazoe Y
Toxicol Lett; 2012 Jan; 208(2):185-91. PubMed ID: 22101211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
